PRF Technologies Ltd. (PRFX)
NASDAQ: PRFX · Real-Time Price · USD
1.510
-0.090 (-5.63%)
At close: Jun 26, 2026, 4:00 PM EDT
1.480
-0.030 (-1.99%)
After-hours: Jun 26, 2026, 7:57 PM EDT
PRF Technologies Employees
As of December 31, 2025, PRF Technologies had 7 total employees, including 6 full-time and 1 part-time employees. The number of employees increased by 1 or 16.67% compared to the previous year.
Employees
7
Change (1Y)
1
Growth (1Y)
16.67%
Revenue / Employee
$2,429
Profits / Employee
-$691,143
Market Cap
4.59M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Universe Pharmaceuticals INC | 216 |
| Biofrontera | 94 |
| Sunshine Biopharma | 50 |
| cbdMD | 42 |
| RedHill Biopharma | 13 |
| InMed Pharmaceuticals | 13 |
| Sonoma Pharmaceuticals | 10 |
| Gelteq | 8 |
PRFX News
- 2 days ago - PRF Technologies announces expanded results from PRF-110 study - TheFly
- 2 days ago - PRF Technologies Reports Expanded Preclinical Results for PRF-110 in Head-to-Head Comparison with Approved Benchmark - GlobeNewsWire
- 5 days ago - PRF Technologies files to sell 7.5M ordinary shares for holders - TheFly
- 4 weeks ago - Why Is Penny Stock PRF Technologies (PRFX) Up Today? - TipRanks
- 4 weeks ago - PRF Technologies Advances DeepSolar Predict™ Toward Commercial Launch as AI Platform Targets Revenue Optimization Across Renewable Energy Markets - GlobeNewsWire
- 4 weeks ago - PRF Technologies announces results from study comparing PRF-110 to Zynrelef - TheFly
- 4 weeks ago - PRF Technologies Announces PRF-110 Demonstrated Sustained 72-Hour Analgesic Activity Comparable to Approved, Commercially Available Benchmark in Head-to-Head Preclinical Study - GlobeNewsWire
- 6 weeks ago - PRF Technologies registers to sell 3M ordinary shares for holders - TheFly